218. アルポート症候群 Alport syndrome Clinical trials / Disease details

臨床試験数 : 30 / 薬物数 : 36 - (DrugBank : 15) / 標的遺伝子数 : 8 - 標的パスウェイ数 : 46

3 trials found

diseases per page:

Showing 1 to 3 of 3 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04937907 (ClinicalTrials.gov)	September 8, 2021	17/6/2021	Study of Hydroxychloroquine in Patients With X-linked Alport Syndrome in China (CHXLAS)	Efficacy and Safety of Hydroxychloroquine in Patients With X-linked Alport Syndrome in China (CHXLAS ...	Alport Syndrome, X-Linked	Drug: Hydroxychloroquine Sulfate 100 milligram (mg) Tab;Drug: Benazepril hydrochloride 10 milligram (m ...	Shanghai Children's Hospital	NULL	Recruiting	3 Years	18 Years	All	50	Phase 2	China
2	ChiCTR2000036799	2020-10-01	2020-08-25	Construction and clinical transformation of integrated platform for accurate diagnosis and treatment ...	Construction and clinical transformation of integrated platform for accurate diagnosis and treatment ...	Alport Syndrome	experimental group:Hydroxychloroquine+ BenazeprilHydrochloridec;control group:placebo + benazeprilhy ...	Shanghai Children's Hospital	NULL	Pending	0	18	Both	experimental group:25;control group:25;	N/A	China
3	NCT00309257 (ClinicalTrials.gov)	January 2004	30/3/2006	Effects of an Intensified Treatment With ACE-I,ATA II and Statins in Alport Syndrome	Effects of an Intensified Treatment With ACE-inhibitors, Angiotensin II Receptor Antagonists and Sta ...	Alport Syndrome	Drug: ACE I, ATA II and Statins;Drug: Benazepril , Valsartan and Fluvastatin	Mario Negri Institute for Pharmacological Research	NULL	Completed	15 Years	70 Years	Both	9	Phase 2	Italy

First Previous1Next Last